Moraes de Souza, C.; Tanir, T.; Orellana, M.; Escalante, A.; Koeris, M.S.
Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations. Pharmaceuticals 2021, 14, 895.
https://doi.org/10.3390/ph14090895
AMA Style
Moraes de Souza C, Tanir T, Orellana M, Escalante A, Koeris MS.
Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations. Pharmaceuticals. 2021; 14(9):895.
https://doi.org/10.3390/ph14090895
Chicago/Turabian Style
Moraes de Souza, Carolina, Tayfun Tanir, Marvin Orellana, Aster Escalante, and Michael Sandor Koeris.
2021. "Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations" Pharmaceuticals 14, no. 9: 895.
https://doi.org/10.3390/ph14090895
APA Style
Moraes de Souza, C., Tanir, T., Orellana, M., Escalante, A., & Koeris, M. S.
(2021). Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations. Pharmaceuticals, 14(9), 895.
https://doi.org/10.3390/ph14090895